{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:08:27Z","timestamp":1772032107013,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006196","name":"University of Oulu","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13526-7","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:22:29Z","timestamp":1760012549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of kidney function impairment with healthcare service utilisation in individuals with type 2 diabetes: an observational follow-up study in primary care"],"prefix":"10.1186","volume":"25","author":[{"given":"Henry","family":"Sundqvist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Hagn\u00e4s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Jokelainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Ronkainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Mikkola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"Pasanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveliina","family":"Heikkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"13526_CR1","doi-asserted-by":"publisher","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"13526_CR2","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. 9th edn. Brussels. Belgium: 2019. International Diabetes Federation; 2019. Available from: https:\/\/www.diabetesatlas.org"},{"key":"13526_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrneph.2015.173","volume":"12","author":"MC Thomas","year":"2016","unstructured":"Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12:73\u201381. https:\/\/doi.org\/10.1038\/nrneph.2015.173.","journal-title":"Nat Rev Nephrol"},{"key":"13526_CR4","unstructured":"Finnish Registry for Kidney Diseases. (national quality register) 2012\u20132023 report, the national institute for health and welfare, Finland. Available from: https:\/\/www.thl.fi\/kansallisten-laaturekisterien-raportit\/munuaistautirekisteri\/"},{"key":"13526_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"JL Harding","year":"2019","unstructured":"Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62:3\u201316. https:\/\/doi.org\/10.1007\/s00125-018-4711-2.","journal-title":"Diabetologia"},{"key":"13526_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1204\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","journal-title":"Lancet"},{"key":"13526_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pcd.2014.06.001","volume":"9","author":"K Mets\u00e4rinne","year":"2015","unstructured":"Mets\u00e4rinne K, Br\u00f6ijersen A, Kantola I, Niskanen L, Rissanen A, Appelroth, Tina, et al. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care. Prim Care Diabetes. 2015;9:31\u20138. https:\/\/doi.org\/10.1016\/j.pcd.2014.06.001.","journal-title":"Prim Care Diabetes"},{"key":"13526_CR8","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.clinthera.2009.10.020","volume":"31","author":"CE Koro","year":"2009","unstructured":"Koro CE, Lee BH, Bowlin SJ. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the united States. Clin Ther. 2009;31:2608\u201317. https:\/\/doi.org\/10.1016\/j.clinthera.2009.10.020.","journal-title":"Clin Ther"},{"key":"13526_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/ijcp.12640","volume":"69","author":"J Cid Ruzafa","year":"2015","unstructured":"Cid Ruzafa J, Paczkowski R, Boye KS, Di Tanna GL, Sheetz MJ, Donaldson R, et al. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study. Int J Clin Pract. 2015;69:871\u201382. https:\/\/doi.org\/10.1111\/ijcp.12640.","journal-title":"Int J Clin Pract"},{"key":"13526_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.pcd.2020.05.005","volume":"14","author":"M Hagn\u00e4s","year":"2020","unstructured":"Hagn\u00e4s M, Sundqvist H, Jokelainen J, Tumminia A, Vinciguerra F, Loreto C, et al. The prevalence of chronic kidney disease and screening of renal function in type 2 diabetic patients in Finnish primary healthcare. Prim Care Diabetes. 2020;14:639\u201344. https:\/\/doi.org\/10.1016\/j.pcd.2020.05.005.","journal-title":"Prim Care Diabetes"},{"key":"13526_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2369-14-46","volume":"14","author":"A Rodriguez-Poncelas","year":"2013","unstructured":"Rodriguez-Poncelas A, Garre-Olmo J, Franch-Nadal J, Diez-Espino J, Mundet-Tuduri X. Prevalence of chronic kidney disease in patients with type 2 diabetes in spain: PERCEDIME2 study. BMC Nephrol. 2013;14:8. https:\/\/doi.org\/10.1186\/1471-2369-14-46.","journal-title":"BMC Nephrol"},{"key":"13526_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","volume":"102","author":"P Rossing","year":"2022","unstructured":"Rossing P, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, et al. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102:S1\u2013127. https:\/\/doi.org\/10.1016\/j.kint.2022.06.008.","journal-title":"Kidney Int"},{"key":"13526_CR13","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.2337\/dc23-S011","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 11. Chronic kidney disease and risk management: standards of care in Diabetes\u20142023. Diabetes Care. 2023;46:S191\u2013202. https:\/\/doi.org\/10.2337\/dc23-S011.","journal-title":"Diabetes Care"},{"key":"13526_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12882-022-02979-1","volume":"23","author":"H Sundqvist","year":"2022","unstructured":"Sundqvist H, Heikkala E, Jokelainen J, Russo G, Mikkola I, Hagn\u00e4s M. Association of renal function screening frequency with renal function decline in patients with type 2 diabetes: a real-world study in primary health care. BMC Nephrol. 2022;23:356. https:\/\/doi.org\/10.1186\/s12882-022-02979-1.","journal-title":"BMC Nephrol"},{"key":"13526_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1464-5491.2012.03698.x","volume":"29","author":"N Hex","year":"2012","unstructured":"Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29:855\u201362. https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03698.x.","journal-title":"Diabet Med"},{"key":"13526_CR16","unstructured":"Li R, Bilik D, Brown MB, Zhang P, Ettner SL, Ackermann RT, et al. Medical costs associated type 2 diabetes complications comorbidities. 2015;16."},{"key":"13526_CR17","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1080\/13696998.2023.2264715","volume":"26","author":"P McEwan","year":"2023","unstructured":"McEwan P, Hafner M, Jha V, Correa-Rotter R, Chernin G, De Nicola L, et al. Translating the efficacy of Dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis. J Med Econ. 2023;26:1407\u201316. https:\/\/doi.org\/10.1080\/13696998.2023.2264715.","journal-title":"J Med Econ"},{"key":"13526_CR18","doi-asserted-by":"publisher","unstructured":"Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, et al. Economic costs of diabetes in the U.S. in 2022. Diabetes Care. 2023;dci230085. https:\/\/doi.org\/10.2337\/dci23-0085.","DOI":"10.2337\/dci23-0085"},{"key":"13526_CR19","doi-asserted-by":"publisher","unstructured":"KDIGO Guideline. Kidney Disease: Improving Global Outcomes (KDIGO) CKD work Group. KDIGO 2012 clinical practice guideline for theevaluation and management of chronic kidney disease. Kidney inter. Off J Int Soc Nephrol. 2013;3(Suppl):1\u2013150. https:\/\/doi.org\/10.1038\/kisup.2012.73.","DOI":"10.1038\/kisup.2012.73"},{"issue":"1","key":"13526_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1186\/s12913-021-06989-x","volume":"21","author":"E Heikkala","year":"2021","unstructured":"Heikkala E, Mikkola I, Jokelainen J, Timonen M, Hagn\u00e4s M. Multimorbidity and achievement of treatment goals among patients with type 2 diabetes: a primary care, real-world study. BMC Health Serv Res. 2021;21(1):964.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"13526_CR21","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.18553\/jmcp.2020.26.12.1506","volume":"26","author":"K Folkerts","year":"2020","unstructured":"Folkerts K, Petruski-Ivleva N, Kelly A, Fried L, Blankenburg M, Gay A, et al. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. Administrative claims database. JMCP. 2020;26(12):1506\u201316.","journal-title":"JMCP"},{"key":"13526_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/02813432.2023.2255062","volume":"41","author":"E Mellanen","year":"2023","unstructured":"Mellanen E, Kauppila T, Kautiainen H, Lehto M, Rahkonen O, Pitk\u00e4l\u00e4 K, et al. Use of primary health care services and mortality in older patients with type 2 diabetes with or without comorbidities. Scand J Prim Health Care. 2023;41:392\u20139. https:\/\/doi.org\/10.1080\/02813432.2023.2255062.","journal-title":"Scand J Prim Health Care"},{"key":"13526_CR23","doi-asserted-by":"publisher","first-page":"e054654","DOI":"10.1136\/bmjopen-2021-054654","volume":"12","author":"S Hodgson","year":"2022","unstructured":"Hodgson S, Morgan-Harrisskitt J, Hounkpatin H, Stuart B, Dambha-Miller H. Primary care service utilisation and outcomes in type 2 diabetes: a longitudinal cohort analysis. BMJ Open. 2022;12:e054654. https:\/\/doi.org\/10.1136\/bmjopen-2021-054654.","journal-title":"BMJ Open"},{"key":"13526_CR24","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/dme.13806","volume":"35","author":"KN O\u2019Neill","year":"2018","unstructured":"O\u2019Neill KN, McHugh SM, Tracey ML, Fitzgerald AP, Kearney PM. Health service utilization and related costs attributable to diabetes. Diabet Med. 2018;35:1727\u201334. https:\/\/doi.org\/10.1111\/dme.13806.","journal-title":"Diabet Med"},{"key":"13526_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12875-022-01844-2","volume":"23","author":"A-K Aro","year":"2022","unstructured":"Aro A-K, Karjalainen M, Tiihonen M, Kautiainen H, Saltevo J, Haanp\u00e4\u00e4 M, et al. Use of primary health care services among older patients with and without diabetes. BMC Prim Care. 2022;23:233. https:\/\/doi.org\/10.1186\/s12875-022-01844-2.","journal-title":"BMC Prim Care"},{"issue":"2","key":"13526_CR26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s12325-020-01607-4","volume":"38","author":"O Darlington","year":"2021","unstructured":"Darlington O, Dickerson C, Evans M, McEwan P, S\u00f6rstadius E, Sugrue D, et al. Costs and healthcare resource use associated with risk of cardiovascular morbidity in patients with chronic kidney disease: evidence from a systematic literature review. Adv Ther. 2021;38(2):994\u20131010.","journal-title":"Adv Ther"},{"key":"13526_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2337\/cd17-0119","volume":"36","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Standards of medical care in Diabetes\u20142018 abridged for primary care providers. Clin Diabetes. 2018;36:14\u201337. https:\/\/doi.org\/10.2337\/cd17-0119.","journal-title":"Clin Diabetes"},{"key":"13526_CR28","volume-title":"Building primary care in a changing Europe","year":"2015","unstructured":"Kringos DS, Boerma WGW, Hutchinson A, Saltman RB, editors. Building primary care in a changing Europe. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2015."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13526-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13526-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13526-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:22:33Z","timestamp":1760012553000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13526-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13526"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13526-7","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Lapland Central Hospital, Rovaniemi, Finland (Reg.no. 05\/2018). Informed consent to participate from individuals is not required in a registry-based study according to Finnish legislation (Personal Data Act 523\/1999). All methods were carried out following relevant guidelines and regulations. The access to the data used in the present study was authorised by the administrative senior physician of the city of Rovaniemi, Lapland, Finland. Only pseudonymised data were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1340"}}